10-QPeriod: Q1 FY2020

CARPENTER TECHNOLOGY CORP Quarterly Report for Q1 Ended Sep 30, 2019

Filed October 24, 2019For Securities:CRS

Summary

Carpenter Technology Corporation (CRS) reported its first quarter fiscal year 2020 results, demonstrating year-over-year growth in sales and earnings. Net sales increased by 2% to $585.4 million, driven by strong performance in the Aerospace and Defense and Medical sectors. Excluding surcharge revenue, net sales grew by a more significant 7%, indicating robust underlying demand and a favorable product mix. The company's operational improvements and strategic investments are reflected in its improved profitability, with gross profit increasing by 23% and operating income up by 33% compared to the prior year period. Notably, adjusted gross margin and adjusted operating margin (excluding surcharges) showed substantial improvements, suggesting effective cost management and pricing strategies. Despite a decrease in cash from operations and negative free cash flow, driven by working capital investments and capital expenditures, the company maintains a solid liquidity position with significant available borrowing capacity.

Financial Statements
Beta

Key Highlights

  • 1Net sales increased by 2% to $585.4 million, with a 7% increase excluding raw material surcharges, indicating strong underlying business performance.
  • 2Aerospace & Defense and Medical sectors showed significant sales growth, up 14% and 4% respectively (19% and 11% excluding surcharges), highlighting strength in key growth markets.
  • 3Gross profit increased by 23% to $112.6 million, with an adjusted gross margin (excluding surcharges) improving to 23.1% from 20.1% year-over-year.
  • 4Operating income rose by 33% to $59.8 million, with an adjusted operating margin (excluding surcharges) expanding to 12.3% from 9.9% year-over-year.
  • 5Inventories increased by $50 million sequentially to $837.6 million, a key area to monitor for working capital efficiency.
  • 6Cash from operations decreased to $0.7 million from $9.4 million year-over-year, leading to negative free cash flow of $(56.4) million, primarily due to increased working capital investments and capital expenditures.
  • 7The company reported a material weakness in internal control over financial reporting related to the billing process, with remediation expected by the end of fiscal year 2020.

Frequently Asked Questions

Net sales increased by 2% to $585.4 million. Excluding raw material surcharge revenue, sales grew by 7%, primarily driven by strong demand and a favorable product mix in the Aerospace & Defense and Medical end-use markets.

Profitability improved significantly. Gross profit increased by 23% to $112.6 million, and operating income rose by 33% to $59.8 million. When excluding the impact of raw material surcharges, adjusted gross margin improved to 23.1% and adjusted operating margin improved to 12.3%, demonstrating underlying margin expansion.

The company reported $24.6 million in cash and cash equivalents and $316.5 million in available borrowing capacity under its credit facility, totaling $341.1 million in liquidity. While cash from operations decreased and free cash flow was negative due to investments, management believes its liquidity is sufficient for its needs over the foreseeable future.

A material weakness in internal control over financial reporting related to the accuracy and completeness of billing data inputs was disclosed, though no misstatements were identified. The company is implementing remediation efforts expected to be completed by the end of fiscal year 2020. Additionally, while not impacting current financials, the company is subject to various environmental and legal contingencies.